A roadmap for enterotoxigenic Escherichia coli vaccine development based on volunteer challenge studies
JournalHuman Vaccines and Immunotherapeutics
PublisherTaylor and Francis Inc.
MetadataShow full item record
AbstractEnterotoxigenic Escherichia coli (ETEC) is a major cause of travelers’ diarrhea and of diarrhea among young children in developing countries. Experimental challenge studies in adult volunteers have played a pivotal role in establishing ETEC as an enteric pathogen, elucidating its pathogenesis by identifying specific virulence attributes, characterizing the human immune response to clinical and sub-clinical ETEC infection and assessing preliminarily the clinical acceptability, immunogenicity and efficacy of prototype ETEC vaccines. This review provides a historical perspective of experimental challenge studies with ETEC. It summarizes pioneering early studies carried out by investigators at the University of Maryland School of Medicine to show how those studies provided key information that influenced the directions taken by many research groups to develop vaccines to prevent ETEC. In addition, key experimental challenge studies undertaken at other institutions will also be cited. © 2019 The Author(s).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068893813&origin=inward; http://hdl.handle.net/10713/10118
- Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity.
- Authors: Huang J, Duan Q, Zhang W
- Issue date: 2018 Aug 1
- Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa<sub>N12S</sub>-mnLT<sub>G192G/L211A</sub>-Derived Antibodies Inhibit Adherence of Seven Adhesins, Neutralize Enterotoxicity of LT and STa Toxins, and Protect Piglets against Diarrhea.
- Authors: Nandre R, Ruan X, Lu T, Duan Q, Sack D, Zhang W
- Issue date: 2018 Mar
- Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
- Authors: Harro C, Louis Bourgeois A, Sack D, Walker R, DeNearing B, Brubaker J, Maier N, Fix A, Dally L, Chakraborty S, Clements JD, Saunders I, Darsley MJ
- Issue date: 2019 Mar 28
- Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTa<sub>N12S</sub>-dmLT protect against STa+ enterotoxigenic Escherichia coli (ETEC) diarrhea in a pig model.
- Authors: Nandre RM, Duan Q, Wang Y, Zhang W
- Issue date: 2017 Jan 23
- Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
- Authors: Chakraborty S, Harro C, DeNearing B, Ram M, Feller A, Cage A, Bauers N, Bourgeois AL, Walker R, Sack DA
- Issue date: 2016 Jan